Search All News
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
A new study in women found that shortening sleep by just 90 minutes for a few weeks increased insulin resistance, a risk factor for type 2 diabetes.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
- November 19, 2021
Relatives of people with type 1 diabetes are 15 times more likely than the general population to develop the disease, and studies at Columbia are trying to find ways to delay or stop the process.
- November 5, 2021
When Emma was diagnosed with type 1 diabetes at age 10, she worried she would have to give up dance. But her team at Columbia's Naomi Berrie Diabetes Center has kept her on her toes.
- December 1, 2020
New findings suggest a hormone called lipocalin-2, previously found to suppress food intake in mice, may also prevent weight gain in humans.
- November 12, 2020
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
- November 19, 2019
Columbia University has presented the 2019 Naomi Berrie Award for Outstanding Achievement in Diabetes Research to Alvin C. Powers, MD.
- April 9, 2019
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.